Muhammad Ahmad, Aizaz Ali, Tahreem Mari, Fariha Hasan, Saeed Ali, Mohamad Sharbatji, Malik Waleed Zeb Khan, Jibran Ikram
{"title":"美国胃恶性肿瘤死亡率的趋势和差异:1999年至2020年的全国分析","authors":"Muhammad Ahmad, Aizaz Ali, Tahreem Mari, Fariha Hasan, Saeed Ali, Mohamad Sharbatji, Malik Waleed Zeb Khan, Jibran Ikram","doi":"10.1007/s12029-025-01295-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Gastric malignancies remain a significant public health concern and a major contributor to cancer-related mortality worldwide. This study aimed to analyze trends and disparities in gastric malignancy mortality across socio-demographic and regional factors in the United States (US) from 1999 to 2020.</p><p><strong>Methods: </strong>A retrospective analysis was conducted using CDC WONDER data from 1999 to 2020 for adults aged ≥ 25 years. Data on demographics (age, sex, race/ethnicity), urban-rural classification, and regional trends were extracted. Age-adjusted mortality rates (AAMR) were calculated using the 2000 U.S. population as a reference, with trends analyzed using Joinpoint regression to determine annual percentage changes (APC) with statistical significance (P < 0.05).</p><p><strong>Results: </strong>Between 1999 and 2020, 276,023 deaths due to gastric malignancies were recorded, with 59.3% occurring among males. The AAMR declined from 7.94 in 1999 to 4.66 in 2020, with an overall AAMR of 5.82. The 65 + age group had the highest AAMR (20.83), while the 25-44 age group had the lowest (0.74). Males consistently reported higher AAMRs (7.60) than females (4.85). NH Black individuals had the highest overall AAMR (10.82), while NH White individuals had the lowest (4.62). Urban areas had higher AAMRs (5.95) than rural areas (5.07).</p><p><strong>Conclusion: </strong>Mortality from gastric malignancies has declined in the U.S. from 1999 to 2020; however, higher mortality rates in NH Black individuals, males, and urban dwellers highlight the need for targeted interventions and equitable access to prevention and treatment resources. Future research should focus on identifying actionable solutions to mitigate these gaps.</p>","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"56 1","pages":"168"},"PeriodicalIF":1.6000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12325418/pdf/","citationCount":"0","resultStr":"{\"title\":\"Trends and Disparities in Mortality Due to Gastric Malignancies the United States: A Nationwide Analysis from 1999 to 2020.\",\"authors\":\"Muhammad Ahmad, Aizaz Ali, Tahreem Mari, Fariha Hasan, Saeed Ali, Mohamad Sharbatji, Malik Waleed Zeb Khan, Jibran Ikram\",\"doi\":\"10.1007/s12029-025-01295-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Gastric malignancies remain a significant public health concern and a major contributor to cancer-related mortality worldwide. This study aimed to analyze trends and disparities in gastric malignancy mortality across socio-demographic and regional factors in the United States (US) from 1999 to 2020.</p><p><strong>Methods: </strong>A retrospective analysis was conducted using CDC WONDER data from 1999 to 2020 for adults aged ≥ 25 years. Data on demographics (age, sex, race/ethnicity), urban-rural classification, and regional trends were extracted. Age-adjusted mortality rates (AAMR) were calculated using the 2000 U.S. population as a reference, with trends analyzed using Joinpoint regression to determine annual percentage changes (APC) with statistical significance (P < 0.05).</p><p><strong>Results: </strong>Between 1999 and 2020, 276,023 deaths due to gastric malignancies were recorded, with 59.3% occurring among males. The AAMR declined from 7.94 in 1999 to 4.66 in 2020, with an overall AAMR of 5.82. The 65 + age group had the highest AAMR (20.83), while the 25-44 age group had the lowest (0.74). Males consistently reported higher AAMRs (7.60) than females (4.85). NH Black individuals had the highest overall AAMR (10.82), while NH White individuals had the lowest (4.62). Urban areas had higher AAMRs (5.95) than rural areas (5.07).</p><p><strong>Conclusion: </strong>Mortality from gastric malignancies has declined in the U.S. from 1999 to 2020; however, higher mortality rates in NH Black individuals, males, and urban dwellers highlight the need for targeted interventions and equitable access to prevention and treatment resources. Future research should focus on identifying actionable solutions to mitigate these gaps.</p>\",\"PeriodicalId\":15895,\"journal\":{\"name\":\"Journal of Gastrointestinal Cancer\",\"volume\":\"56 1\",\"pages\":\"168\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12325418/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Gastrointestinal Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s12029-025-01295-9\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Gastrointestinal Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12029-025-01295-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
Trends and Disparities in Mortality Due to Gastric Malignancies the United States: A Nationwide Analysis from 1999 to 2020.
Purpose: Gastric malignancies remain a significant public health concern and a major contributor to cancer-related mortality worldwide. This study aimed to analyze trends and disparities in gastric malignancy mortality across socio-demographic and regional factors in the United States (US) from 1999 to 2020.
Methods: A retrospective analysis was conducted using CDC WONDER data from 1999 to 2020 for adults aged ≥ 25 years. Data on demographics (age, sex, race/ethnicity), urban-rural classification, and regional trends were extracted. Age-adjusted mortality rates (AAMR) were calculated using the 2000 U.S. population as a reference, with trends analyzed using Joinpoint regression to determine annual percentage changes (APC) with statistical significance (P < 0.05).
Results: Between 1999 and 2020, 276,023 deaths due to gastric malignancies were recorded, with 59.3% occurring among males. The AAMR declined from 7.94 in 1999 to 4.66 in 2020, with an overall AAMR of 5.82. The 65 + age group had the highest AAMR (20.83), while the 25-44 age group had the lowest (0.74). Males consistently reported higher AAMRs (7.60) than females (4.85). NH Black individuals had the highest overall AAMR (10.82), while NH White individuals had the lowest (4.62). Urban areas had higher AAMRs (5.95) than rural areas (5.07).
Conclusion: Mortality from gastric malignancies has declined in the U.S. from 1999 to 2020; however, higher mortality rates in NH Black individuals, males, and urban dwellers highlight the need for targeted interventions and equitable access to prevention and treatment resources. Future research should focus on identifying actionable solutions to mitigate these gaps.
期刊介绍:
The Journal of Gastrointestinal Cancer is a multidisciplinary medium for the publication of novel research pertaining to cancers arising from the gastrointestinal tract.The journal is dedicated to the most rapid publication possible.The journal publishes papers in all relevant fields, emphasizing those studies that are helpful in understanding and treating cancers affecting the esophagus, stomach, liver, gallbladder and biliary tree, pancreas, small bowel, large bowel, rectum, and anus. In addition, the Journal of Gastrointestinal Cancer publishes basic and translational scientific information from studies providing insight into the etiology and progression of cancers affecting these organs. New insights are provided from diverse areas of research such as studies exploring pre-neoplastic states, risk factors, epidemiology, genetics, preclinical therapeutics, surgery, radiation therapy, novel medical therapeutics, clinical trials, and outcome studies.In addition to reports of original clinical and experimental studies, the journal also publishes: case reports, state-of-the-art reviews on topics of immediate interest or importance; invited articles analyzing particular areas of pancreatic research and knowledge; perspectives in which critical evaluation and conflicting opinions about current topics may be expressed; meeting highlights that summarize important points presented at recent meetings; abstracts of symposia and conferences; book reviews; hypotheses; Letters to the Editors; and other items of special interest, including:Complex Cases in GI Oncology: This is a new initiative to provide a forum to review and discuss the history and management of complex and involved gastrointestinal oncology cases. The format will be similar to a teaching case conference where a case vignette is presented and is followed by a series of questions and discussion points. A brief reference list supporting the points made in discussion would be expected.